Stock Analysis

Is Richtech Robotics (NASDAQ:RR) Weighed On By Its Debt Load?

NasdaqCM:RR
Source: Shutterstock

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. As with many other companies Richtech Robotics Inc. (NASDAQ:RR) makes use of debt. But is this debt a concern to shareholders?

Why Does Debt Bring Risk?

Debt is a tool to help businesses grow, but if a business is incapable of paying off its lenders, then it exists at their mercy. In the worst case scenario, a company can go bankrupt if it cannot pay its creditors. However, a more frequent (but still costly) occurrence is where a company must issue shares at bargain-basement prices, permanently diluting shareholders, just to shore up its balance sheet. Of course, plenty of companies use debt to fund growth, without any negative consequences. The first step when considering a company's debt levels is to consider its cash and debt together.

Check out our latest analysis for Richtech Robotics

How Much Debt Does Richtech Robotics Carry?

You can click the graphic below for the historical numbers, but it shows that as of March 2024 Richtech Robotics had US$2.14m of debt, an increase on US$681.0k, over one year. But it also has US$8.20m in cash to offset that, meaning it has US$6.05m net cash.

debt-equity-history-analysis
NasdaqCM:RR Debt to Equity History June 8th 2024

How Healthy Is Richtech Robotics' Balance Sheet?

We can see from the most recent balance sheet that Richtech Robotics had liabilities of US$2.91m falling due within a year, and liabilities of US$91.0k due beyond that. Offsetting this, it had US$8.20m in cash and US$3.92m in receivables that were due within 12 months. So it actually has US$9.12m more liquid assets than total liabilities.

This short term liquidity is a sign that Richtech Robotics could probably pay off its debt with ease, as its balance sheet is far from stretched. Simply put, the fact that Richtech Robotics has more cash than debt is arguably a good indication that it can manage its debt safely. There's no doubt that we learn most about debt from the balance sheet. But it is Richtech Robotics's earnings that will influence how the balance sheet holds up in the future. So when considering debt, it's definitely worth looking at the earnings trend. Click here for an interactive snapshot.

In the last year Richtech Robotics wasn't profitable at an EBIT level, but managed to grow its revenue by 31%, to US$9.0m. Shareholders probably have their fingers crossed that it can grow its way to profits.

So How Risky Is Richtech Robotics?

Statistically speaking companies that lose money are riskier than those that make money. And in the last year Richtech Robotics had an earnings before interest and tax (EBIT) loss, truth be told. Indeed, in that time it burnt through US$3.8m of cash and made a loss of US$2.3m. But at least it has US$6.05m on the balance sheet to spend on growth, near-term. Richtech Robotics's revenue growth shone bright over the last year, so it may well be in a position to turn a profit in due course. By investing before those profits, shareholders take on more risk in the hope of bigger rewards. The balance sheet is clearly the area to focus on when you are analysing debt. But ultimately, every company can contain risks that exist outside of the balance sheet. For example - Richtech Robotics has 2 warning signs we think you should be aware of.

If, after all that, you're more interested in a fast growing company with a rock-solid balance sheet, then check out our list of net cash growth stocks without delay.

Valuation is complex, but we're helping make it simple.

Find out whether Richtech Robotics is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.